×
验证码:
换一张
忘记密码?
记住我
切换中国科技网通行证登录
×
切换中国科技网通行证登录
登录
中文版
|
English
中国科学院合肥物质科学研究院机构知识库
Knowledge Management System of Hefei Institute of Physical Science,CAS
登录
注册
ALL
ORCID
题名
作者
学科领域
关键词
文献类型
出处
收录类别
出版者
发表日期
存缴日期
资助项目
学科门类
学习讨论厅
图片搜索
粘贴图片网址
首页
研究单元&专题
作者
文献类型
学科分类
知识图谱
新闻&公告
在结果中检索
研究单元&专题
中科院强磁场科学中... [27]
合肥创新院 [2]
医学 [2]
作者
刘青松 [36]
王文超 [27]
王傲莉 [24]
齐紫平 [18]
吴宏 [17]
胡晨 [15]
更多...
发表日期
2023 [1]
2022 [1]
2021 [2]
2020 [3]
2019 [5]
2018 [5]
更多...
语种
英语 [33]
出处
JOURNAL O... [10]
EUROPEAN J... [5]
ONCOTARGET [5]
ACTA PHARM... [2]
CANCER BIO... [2]
SIGNAL TRA... [2]
更多...
资助项目
Frontier S... [8]
Natural Sc... [5]
Natural Sc... [5]
CASHIPS Di... [4]
High Magne... [4]
National N... [4]
更多...
资助机构
National ... [12]
Natural S... [10]
Frontier S... [8]
China "Tho... [7]
Chinese Ac... [7]
"Hundred T... [5]
更多...
收录类别
SCI [34]
摘要
文献类型
期刊论文 [36]
×
知识图谱
HFCAS OpenIR
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
(本次检索基于用户作品认领结果)
浏览/检索结果:
共36条,第1-10条
帮助
限定条件
作者:刘青松
第一作者
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
期刊影响因子升序
期刊影响因子降序
发表日期升序
发表日期降序
WOS被引频次升序
WOS被引频次降序
提交时间升序
提交时间降序
作者升序
作者降序
Predicting and overcoming resistance to CDK9 inhibitors for cancer therapy
期刊论文
ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13
作者:
Hua, Chen
;
Shena, Lijuan
;
Zoua, Fengming
;
Wua, Yun
;
Wanga, Beilei
;
Wanga, Aoli
;
Wud, Chao
;
Wanga, Li
;
Liua, Jing
;
Wanga, Wenchao
;
Liua, Qingsong
收藏
  |  
浏览/下载:39/0
  |  
提交时间:2023/11/10
Acquired resistance mutations
CDK9 inhibitors
Transcription
Single nucleotide polymorphisms
BAY1251152
CHMFL-26 is a highly potent irreversible HER2 inhibitor for use in the treatment of HER2-positive and HER2-mutant cancers
期刊论文
ACTA PHARMACOLOGICA SINICA, 2022
作者:
Cao, Jiang-yan
;
Qi, Shuang
;
Wu, Hong
;
Wang, Ao-li
;
Liu, Qing-wang
;
Li, Xi-xiang
;
Wang, Bei-lei
;
Ge, Juan
;
Zou, Feng-ming
;
Chen, Cheng
;
Wang, Jun-jie
;
Hu, Chen
;
Liu, Jing
;
Wang, Wen-chao
;
Liu, Qing-song
收藏
  |  
浏览/下载:104/0
  |  
提交时间:2022/03/28
HER2
breast cancers
gastric cancers
irreversible inhibitor
drug resistance
An overview of kinase downregulators and recent advances in discovery approaches
期刊论文
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 卷号: 6
作者:
Wang, Beilei
;
Wu, Hong
;
Hu, Chen
;
Wang, Haizhen
;
Liu, Jing
;
Wang, Wenchao
;
Liu, Qingsong
收藏
  |  
浏览/下载:76/0
  |  
提交时间:2022/01/25
Nanocrystal-loaded liposome for targeted delivery of poorly water-soluble antitumor drugs with high drug loading and stability towards efficient cancer therapy
期刊论文
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 卷号: 599
作者:
Liang, Huamin
;
Zou, Fengming
;
Liu, Qingwang
;
Wang, Beilei
;
Fu, Liyi
;
Liang, Xiaofei
;
Liu, Jing
;
Liu, Qingsong
收藏
  |  
浏览/下载:53/0
  |  
提交时间:2021/05/17
Liposome
Drug nanocrystal
Core-shell
Drug delivery
Tumor therapy
BCR-ABL
Discovery of a highly potent and selective Bruton's tyrosine kinase inhibitor avoiding impairment of ADCC effects for B-cell non-Hodgkin lymphoma
期刊论文
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 卷号: 5
作者:
Liu, Juan
;
Liang, Qianmao
;
Wang, Aoli
;
Zou, Fengming
;
Qi, Ziping
;
Yu, Kailin
;
Liu, Qingwang
;
Chen, Cheng
;
Liu, Jing
;
Liu, Qingsong
收藏
  |  
浏览/下载:51/0
  |  
提交时间:2020/11/30
Repurposing of Kinase Inhibitors for Treatment of COVID-19
期刊论文
PHARMACEUTICAL RESEARCH, 2020, 卷号: 37
作者:
Weisberg, Ellen
;
Parent, Alexander
;
Yang, Priscilla L.
;
Sattler, Martin
;
Liu, Qingsong
;
Liu, Qingwang
;
Wang, Jinhua
;
Meng, Chengcheng
;
Buhrlage, Sara J.
;
Gray, Nathanael
;
Griffin, James D.
收藏
  |  
浏览/下载:40/0
  |  
提交时间:2020/10/26
Coronavirus
SARS-CoV-2
SARS-CoV
MERS-CoV
kinase inhibitors
pharmacokinetics
antiviral therapy
COVID-19
Osimertinib successfully combats EGFR-negative glioblastoma cells by inhibiting the MAPK pathway
期刊论文
ACTA PHARMACOLOGICA SINICA, 2020
作者:
Chen, Cheng
;
Cheng, Chuan-dong
;
Wu, Hong
;
Wang, Zuo-wei
;
Wang, Li
;
Jiang, Zong-ru
;
Wang, Ao-li
;
Hu, Chen
;
Dong, Yong-fei
;
Niu, Wan-xiang
;
Qi, Shuang
;
Qi, Zi-ping
;
Liu, Jing
;
Wang, Wen-chao
;
Niu, Chao-shi
;
Liu, Qing-song
浏览
  |  
Adobe PDF(3476Kb)
  |  
收藏
  |  
浏览/下载:101/36
  |  
提交时间:2020/11/26
glioblastoma
osimertinib
temozolamide
MAPK-signaling pathway
MNK
eukaryotic translation initiation factor 4E
Discovery and characterization of a novel highly potent and selective type II native and drug-resistant V299L mutant BCR-ABL inhibitor (CHMFL-ABL-039) for Chronic Myeloid Leukemia (CML)
期刊论文
CANCER BIOLOGY & THERAPY, 2019, 卷号: 20, 期号: 6, 页码: 877-885
作者:
Wu, Jiaxin
;
Wang, Aoli
;
Li, Xixiang
;
Chen, Cheng
;
Qi, Ziping
;
Hu, Chen
;
Wang, Wenliang
;
Wu, Hong
;
Huang, Tao
;
Zhao, Ming
;
Wang, Wenchao
;
Hu, Zhenquan
;
Liu, Qingwang
;
Wang, Beilei
;
Wang, Li
;
Li, Lili
;
Ge, Jian
;
Ren, Tao
;
Xia, Ruixiang
;
Liu, Jing
收藏
  |  
浏览/下载:58/0
  |  
提交时间:2019/11/27
BCR-ABL
PDGFR
chronic myeloid leukemia
kinase inhibitor
Discovery of 2-(4-Chloro-3-(trifluoromethyl)phenyl)-N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)acetamide (CHMFL-KIT-64) as a Novel Orally Available Potent Inhibitor against Broad-Spectrum Mutants of
期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2019
作者:
Yun Wu
;
Beilei Wang
;
Junjie Wang
;
Qi S(亓爽)
;
Fengming Zou
;
Ziping Qi
;
Feiyang Liu
;
Wenchao Wang
;
Qingsong Liu
;
Jing Liu
浏览
  |  
Adobe PDF(5207Kb)
  |  
收藏
  |  
浏览/下载:129/65
  |  
提交时间:2020/10/20
Discovery of N-(4-(6-Acetamidopyrimidin-4-yloxy)phenyl)-2-(2-(trifluoromethyl)phenyl)acetamide (CHMFL-FLT3-335) as a Potent FMS-like Tyrosine Kinase 3 Internal Tandem Duplication (FLT3-ITD) Mutant Selective Inhibitor for Acute Myeloid Leukemia
期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 卷号: 62, 期号: 2, 页码: 875-892
作者:
Liang, Xiaofei
;
Wang, Beilei
;
Chen, Cheng
;
Wang, Aoli
;
Hu, Chen
;
Zou, Fengming
;
Yu, Kailin
;
Liu, Qingwang
;
Li, Feng
;
Hu, Zhenquan
;
Lu, Tingting
;
Wang, Junjie
;
Wang, Li
;
Weisberg, Ellen L.
;
Li, Lili
;
Xia, Ruixiang
;
Wang, Wenchao
;
Ren, Tao
;
Ge, Jian
;
Liu, Jing
;
Liu, Qinsong
浏览
  |  
Adobe PDF(13868Kb)
  |  
收藏
  |  
浏览/下载:377/322
  |  
提交时间:2020/05/21